Neurocrine Biosciences (NBIX) Wānana Kūʻai Kūʻai
Kaʻu kumukūʻai hope$138.08Hoʻohou ʻia 25 Kep. 2026 19:59 UTC
Hoʻololi-0.62%
Hōʻoia AI: NBIX
Hoʻopuka ka AI i kahi kumukūʻai pahuhopu no ka lā kālepa aʻe, ka hopena pule a me ka hopena mahina. Hoʻomākaukau ʻia ka hoʻololi mai ka kumukūʻai hou loa. He helnau kūlana helu wale nō kēia, ʻaʻole he ʻōlelo aʻoaʻo hoʻopukapuka.
Kumukūʻai ma luna o nā mahina 6 i hala
Hōʻike ʻo Premium i nā pahuhopu kumukūʻai o ka AI no 1 lā, 1 pule a me 1 mahina no kēia a me nā stock ʻē aʻe.
Wehe iā Premium🔒 Moʻolelo hōʻike wānana
The forecast track record — every past forecast next to the actual close — is part of Premium.
Wehe iā PremiumE pili ana i kēia Hui
Neurocrine Biosciences, Inc. (NBIX) researches and develops therapeutic agents for the treatment of psycho-neurological, neuroinflammatory, and neurodegenerative diseases and disorders, as well as for neuroses, depression, Alzheimer’s disease, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
